1. Home
  2. SHFS vs SNTI Comparison

SHFS vs SNTI Comparison

Compare SHFS & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHFS
    SELLHOLDBUYas of 9 hours ago
  • SNTI
    SELLHOLDBUYas of 9 hours ago
  • Stock Information
  • Founded
  • SHFS 2015
  • SNTI 2016
  • Country
  • SHFS United States
  • SNTI United States
  • Employees
  • SHFS N/A
  • SNTI N/A
  • Industry
  • SHFS Finance: Consumer Services
  • SNTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • SHFS Finance
  • SNTI Health Care
  • Exchange
  • SHFS Nasdaq
  • SNTI Nasdaq
  • Market Cap
  • SHFS 20.8M
  • SNTI 17.8M
  • IPO Year
  • SHFS N/A
  • SNTI N/A
  • Fundamental
  • Price
  • SHFS $2.23
  • SNTI $2.92
  • Analyst Decision
  • SHFS
  • SNTI Strong Buy
  • Analyst Count
  • SHFS 0
  • SNTI 1
  • Target Price
  • SHFS N/A
  • SNTI $12.00
  • AVG Volume (30 Days)
  • SHFS 13.7K
  • SNTI 23.4K
  • Earning Date
  • SHFS 05-12-2025
  • SNTI 05-08-2025
  • Dividend Yield
  • SHFS N/A
  • SNTI N/A
  • EPS Growth
  • SHFS N/A
  • SNTI N/A
  • EPS
  • SHFS N/A
  • SNTI N/A
  • Revenue
  • SHFS $16,102,301.00
  • SNTI N/A
  • Revenue This Year
  • SHFS N/A
  • SNTI N/A
  • Revenue Next Year
  • SHFS N/A
  • SNTI N/A
  • P/E Ratio
  • SHFS N/A
  • SNTI N/A
  • Revenue Growth
  • SHFS N/A
  • SNTI N/A
  • 52 Week Low
  • SHFS $2.11
  • SNTI $1.52
  • 52 Week High
  • SHFS $18.80
  • SNTI $16.94
  • Technical
  • Relative Strength Index (RSI)
  • SHFS 20.29
  • SNTI 35.02
  • Support Level
  • SHFS $4.25
  • SNTI $3.20
  • Resistance Level
  • SHFS $6.68
  • SNTI $3.56
  • Average True Range (ATR)
  • SHFS 0.68
  • SNTI 0.34
  • MACD
  • SHFS -0.24
  • SNTI -0.04
  • Stochastic Oscillator
  • SHFS 2.58
  • SNTI 8.27

Stock Price Comparison Chart: SHFS vs SNTI

SHFS
SNTI
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0123456789101112SHFS VS SNTI

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use